Company / PP&E (Net)
IRADIMED CORP PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$23.9M
FY2025
5-year range
$2.1M / $23.9M
FY2021-FY2025
Trend
+41.9%
vs FY2024
Sector context
#108 of 130
Health Care
What the data says
IRADIMED CORP's pp&e (net) of $24M is lower than 83% of companies in the Health Care sector (FY2025). PP&E (Net) has increased for 4 consecutive years, from $2M in FY2021 to $24M in FY2025.
Based on SEC 10-K filings.
$24M in FY2025 with a 5-year CAGR of +62.3%.
Improved from $9M to $24M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +115.0%
- 5-Year CAGR
- +62.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 130This company $23.9M Sector average $1.3B
▼
-98.2% below sector average
Key checks
Key Insights
- IRADIMED CORP's pp&e (net) has grown for 4 consecutive years.
- 5-year CAGR of +62.3%, indicating consistent growth.
- In FY2025, pp&e (net) increased 41.9% year-over-year.
- Ranks #108 out of 130 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.9M | +41.9% |
| FY2024 | $16.8M | +81.0% |
| FY2023 | $9.3M | +287.1% |
| FY2022 | $2.4M | +16.0% |
| FY2021 | $2.1M | -2.4% |
| FY2020 | $2.1M | +3.2% |
| FY2019 | $2.1M | +9.9% |
| FY2018 | $1.9M | +0.0% |
| FY2017 | $1.9M | +28.3% |
| FY2016 | $1.5M | +60.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026